G6PD and Plasmodium vivax malaria: Based on the government treatment guidelines beginning from the first quarter of 2021, newly diagnosed vivax malaria patients seeking care from VMWs were offered a first dose of standard anti-malarials and were referred to the health centre for G6PD testing and radical cure treatment (Fig. 3).